From approval to access: Europe’s next health imperative
We have a system where approved medicines are not readily available for patients: this is not a failure of science, but of the systems designed to facilitate access.
We have a system where approved medicines are not readily available for patients: this is not a failure of science, but of the systems designed to facilitate access.